Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424).
Ophthalmology
; 126(3): e22-e24, 2019 03.
Article
in En
| MEDLINE
| ID: mdl-30803528
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Juvenile
/
Uveitis
/
Antirheumatic Agents
Type of study:
Health_economic_evaluation
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Ophthalmology
Year:
2019
Document type:
Article
Affiliation country:
Publication country:
EEUU
/
ESTADOS UNIDOS
/
ESTADOS UNIDOS DA AMERICA
/
EUA
/
UNITED STATES
/
UNITED STATES OF AMERICA
/
US
/
USA